No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs139546028 |
chr14:104744610-104744611 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs144201467 |
chr14:104744681-104744682 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs559071816 |
chr14:104744724-104744725 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs569334451 |
chr14:104744730-104744731 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs538556066 |
chr14:104744737-104744738 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs369412239 |
chr14:104744776-104744777 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs554957649 |
chr14:104744778-104744779 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs574898053 |
chr14:104744796-104744797 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs540588657 |
chr14:104744816-104744817 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs550392287 |
chr14:104744824-104744825 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs570261918 |
chr14:104744826-104744827 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs34178085 |
chr14:104744830-104744831 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs545966058 |
chr14:104744865-104744866 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs116303560 |
chr14:104744960-104744961 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs531403742 |
chr14:104745018-104745019 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs542146136 |
chr14:104745080-104745081 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs561607291 |
chr14:104745103-104745104 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs527294493 |
chr14:104745182-104745183 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs185594127 |
chr14:104745205-104745206 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs369591004 |
chr14:104745278-104745279 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs570225026 |
chr14:104745322-104745323 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs145100087 |
chr14:104745333-104745334 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs149099258 |
chr14:104745398-104745399 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs569479252 |
chr14:104745436-104745437 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs143142674 |
chr14:104745437-104745438 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs566348461 |
chr14:104745514-104745515 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs534614310 |
chr14:104745538-104745539 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs555248511 |
chr14:104745539-104745540 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs568744226 |
chr14:104745621-104745622 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs191129911 |
chr14:104745633-104745634 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs554242464 |
chr14:104745696-104745697 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs151186536 |
chr14:104745699-104745700 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs539971144 |
chr14:104745725-104745726 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs79997871 |
chr14:104745726-104745727 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs183141364 |
chr14:104745758-104745759 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs557427390 |
chr14:104745841-104745842 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs12587325 |
chr14:104745918-104745919 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs561669521 |
chr14:104745919-104745920 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs145926242 |
chr14:104745934-104745935 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs531399428 |
chr14:104745936-104745937 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs58148156 |
chr14:104745973-104745974 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs568168666 |
chr14:104745975-104745976 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs35914562 |
chr14:104745977-104745978 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs571973770 |
chr14:104745986-104745987 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs200773607 |
chr14:104746020-104746021 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs188472560 |
chr14:104746052-104746053 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs540907949 |
chr14:104746091-104746092 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs563764982 |
chr14:104746134-104746135 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs532785851 |
chr14:104746135-104746136 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs549859156 |
chr14:104746136-104746137 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|